Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 4/16/2016 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Thomas Aasen?

Thomas H. Aasen

Executive Vice President, Chief Financial Officer and Chief Business Officer

ACADIA Pharmaceuticals Inc.

HQ Phone:  (858) 558-2871

Direct Phone: (858) ***-****direct phone

Email: t***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

ACADIA Pharmaceuticals Inc.

3611 Valley Centre Drive Suite 300

San Diego, California,92130

United States

Company Description

ACADIA is a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders. ACADIA has a pipeline of product candidates led by NUPLAZIDâ„¢ (pimavanserin), fo... more

Find other employees at this company (502)

Web References(63 Total References)


Press Releases - Investors - Acadia

news.acadia-pharm.com [cached]

Thomas H. Aasen, Chief Financial Officer
858-558-2871


BioPharma News » BioPharma Stock Watch

biopharmadirectory.com [cached]

Thomas H. Aasen, CPA
Executive Vice President, Chief Financial Officer, and Chief Business Officer Mr. Aasen has been with ACADIA since April 1998. Prior to joining the company, Mr. Aasen held the position of Senior Director of Finance and Administration at Axys Pharmaceuticals, a publicly-traded, life-sciences company formerly called Sequana Therapeutics, where he was employed from June 1996 to April 1998. Earlier in his career, Mr. Aasen held various financial-management positions including Director of Finance at Genta, Inc., and Director of Accounting at Gen-Probe, Inc., both publicly-traded life-sciences companies as well as Audit Manager at KPMG Peat Marwick. He has over 23 years of professional finance and accounting experience focused primarily on the life-sciences industry. Mr. Aasen received a B.S. degree with honors from San Diego State University, and he is a Certified Public Accountant.


Press Releases - Investors - Acadia

ir.acadia-pharm.com [cached]

Thomas H. Aasen, Executive Vice President,
Chief Financial Officer and Chief Business Officer


Acadia Pharmaceuticals - About Us - Management Team

www.acadia-pharm.com [cached]

Thomas H. Aasen
Thomas H. Aasen is our Executive Vice President, Chief Financial Officer, and Chief Business Officer and has been at ACADIA since April 1998. Prior to joining us, Mr. Aasen held financial management positions at several publicly traded life sciences companies, including Axys Pharmaceuticals, formerly called Sequana Therapeutics, Genta, Inc., and Gen-Probe, Inc. Earlier in his career, Mr. Aasen held various positions in public accounting at KPMG Peat Marwick, including Audit Manager. He has 30 years of professional finance and accounting experience focused primarily on the life sciences industry. Mr. Aasen received a B.S. degree with honors from San Diego State University and is a licensed certified public accountant (inactive status) in the State of California.


www.sec.gov

Thomas H. Aasen is our Executive Vice President, Chief Financial Officer, Chief Business Officer, and Treasurer and has been with the Company since April 1998.
Prior to joining us, Mr. Aasen held financial management positions at several publically traded life sciences companies, including Axys Pharmaceuticals, formerly called Sequana Therapeutics, Genta, Inc., and Gen-Probe, Inc. Earlier in his career, Mr. Aasen held various positions in public accounting at KPMG Peat Marwick, including Audit Manager. He has 30 years of professional finance and accounting experience focused primarily on the life sciences industry. Mr. Aasen received a B.S. degree with honors from San Diego State University and is a licensed certified public accountant (inactive status) in the State of California.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory